Optic Neuritis Treatment Market Size

Optic Neuritis Treatment Market size was over USD 232.1 Million in 2023 and is poised to reach USD 465.54 Million by the end of 2036, growing at around 5.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of optic neuritis treatment is assessed at USD 243.59 Million. The reason behind the growth is impelled by rising incidences of bacterial infections across the globe. Optic neuritis is frequently idiopathic and can occur in combination with infectious disorders such as Lyme disease, and syphilis, since the infection may prompt the immune system to attack the optic nerve as if it were a foreign intruder. As a result, the treatment for optic neuritis becomes crucial to prevent potential optic nerve damage.

The significant increment in the global geriatric population is believed to fuel market growth. For instance, the elderly population is more susceptible to age-related eye diseases such as cataracts, and glaucoma, which may lead to optic neuritis. Ischemic optic neuropathy, which is more common, mostly affects older persons and has an impact on the visual acuity of adults and seniors. Therefore, a significant increment in the global geriatric population is fueling the market.  According to estimates, the number of individuals in the world who are 60 or older will increase to more than 2 billion by 2050.